Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.70 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | NOS3 | P29474 | 3/20 | 0.43 |
| ▸ | NOS1 | P29475 | 3/20 | 0.43 |
| ▸ | NOS2 | P35228 | 3/20 | 0.43 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.38 |
| ▸ | SHBG | P04278 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL128915 | 1.00 | — | — | |
| SCHEMBL11227844 | 1.00 | CYP1A2 (0.70) | CYP1A2SIGMAR1CA1CA2CA4 | |
| SCHEMBL7738781 | 1.00 | CYP1A2 (0.70) | CYP1A2SIGMAR1CA1CA2CA4 | |
| SCHEMBL27988307 | 1.00 | CYP1A2 (0.70) | CYP1A2SIGMAR1CA1CA2CA4 | |
| SCHEMBL3633846 | 1.00 | CYP1A2 (0.70) | CYP1A2SIGMAR1CA1CA2CA4 | |
| SCHEMBL11726232 | 1.00 | CYP1A2 (0.70) | CYP1A2SIGMAR1CA1CA2CA4 | |
| SCHEMBL7741556 | 1.00 | CYP1A2 (0.70) | CYP1A2SIGMAR1CA1CA2CA4 | |
| SCHEMBL905661 | 1.00 | CYP1A2 (0.70) | CYP1A2SIGMAR1CA1CA2CA4 | |
| Ammonia Solution, Strong SCHEMBL2254142 | 0.97 | CYP1A2 (0.67) | CYP1A2SIGMAR1CA1CA2CA4 | |
| Methane SCHEMBL16670259 | 0.97 | CYP1A2 (0.67) | CYP1A2SIGMAR1CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 621 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107628920-B | Preparation method of alkyl substituted naphthalane and application of alkyl substituted naphthalane as jet fuel | 天津大学 | 2020-08-04 | — | — | CN | claimed |
| CN-109647199-A | A kind of preparation method of reverse osmosis membrane and thus obtained reverse osmosis membrane | 时代沃顿科技有限公司 | 2019-04-19 | — | — | CN | claimed |
| CN-109265995-A | A kind of polymerized hindered amine light stabilizer and its application | 北京天罡助剂有限责任公司 | 2019-01-25 | — | — | CN | claimed |
| WO-2013173332-A1 | METHOD FOR SELECTIVE PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM PLANT LIGNIN | Vertichem Corporation (CA) | 2013-11-21 | — | — | WO | claimed |
| WO-2013134756-A1 | A METHOD FOR TIERED PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM LIGNIN | Vertichem Corporation (CA) | 2013-09-12 | — | — | WO | claimed |
| US-20130232853-A1 | METHOD FOR SELECTIVE PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM PLANT LIGNIN | THESIS CHEMISTRY, LLC (US) | 2013-09-12 | — | — | US | claimed |
| US-20130232852-A1 | METHOD FOR TIERED PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM LIGNIN | THESIS CHEMISTRY, LLC (US) | 2013-09-12 | — | — | US | claimed |
| WO-2008009680-A1 | NOVEL HYDROGEN-RICH 1,3-DIALKOXYDISILOXANES AND PROCESSES FOR THEIR PREPARATION AND THEIR USE | TECHNISCHE UNIVERSITÄT BERGAKADEMIE FREIBERG (DE) | 2008-01-24 | — | — | WO | claimed |
| EP-0193065-B1 | Morpholine derivatives, processes for their production and their use as fungicides | BASF AG (DE) | 1995-08-23 | — | — | EP | claimed |
| US-12043817-B1 | Low viscosity lubricating fluid for an electric motor system | AFTON CHEMICAL CORPORATION (US) | 2024-07-23 | — | — | US | disclosed |
| US-20240186044-A1 | MAGNETO RHEOLOGICAL FLUID AND MAGNETO RHEOLOGICAL FLUID DEVICE | FUJIFILM CORPORATION (JP) | 2024-06-06 | — | — | US | disclosed |
| EP-4379756-A1 | MAGNETORHEOLOGICAL FLUID AND MAGNETORHEOLOGICAL FLUID DEVICE | FUJIFILM Corporation (JP) | 2024-06-05 | — | — | EP | disclosed |
| WO-2024106521-A1 | WATER-SOLUBLE PROCESSING OIL STOCK COMPOSITION AND METALWORKING METHOD | ＥＮＥＯＳ株式会社 | 2024-05-23 | — | — | WO | disclosed |
| CN-117730381-A | Magnetic viscous fluid and magnetic viscous fluid device | 富士胶片株式会社 | 2024-03-19 | — | — | CN | disclosed |
| US-4388427-A | NONAQUEOUS DISPERSION OF ADDITION POLYMER IN SOLUTION OF RESIN | TOYO INK MANUFACTURING CO., LTD. (JP) | 1983-06-14 | — | — | US | disclosed |
| US-4301164-A | FOR USE AS ANTIULCER AGENTS, HYPOTENSIVE AGENTS, ANTITHROMBOSIC AGENTS | TORAY INDUSTRIES, INC. (JP) | 1981-11-17 | — | — | US | disclosed |
| US-4299991-A | Formation of hydroperoxides | THE STANDARD OIL COMPANY (US) | 1981-11-10 | — | — | US | disclosed |
| EP-0024943-A1 | 5,6,7-Trinor-4,8-inter-m-phenylene PGI2 derivatives and pharmaceutical compositions containing them | TORAY INDUSTRIES, INC. (JP) | 1981-03-11 | — | — | EP | disclosed |
| US-4152358-A | FROM ALIPHATIC, AROMATIC OR ALICYCLIC HYDROCARBON IN PRESENCE OF PHOSPHATE OF URANIUM, COPPER OR IRON | PETRO-TEX CHEMICAL CORPORATION (US) | 1979-05-01 | — | — | US | disclosed |
| US-3974228-A | BUFFERS | PETRO-TEX CHEMICAL CORPORATION (US) | 1976-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130232852-A1 | METHOD FOR TIERED PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM LIGNIN | DCXR, AGL, GLO1 | CYP1A2 333/4885SIGMAR1 2933/4885CA1 4736/4885 |
| US-20130232853-A1 | METHOD FOR SELECTIVE PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM PLANT LIGNIN | HAAO, HAO2, HACL2 | CYP1A2 88/4885SIGMAR1 2751/4885CA1 3091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.